Weitz & Luxenberg Reflects on Landmark Asbestos Trial

NEW YORK, Aug. 7, 2013 /PRNewswire/ — When asked how he felt about his firm securing a $190-million verdict for five mesothelioma victims this July, Weitz & Luxenberg attorney Danny Kraft Jr. replied, "Fantastic. Justice has been done." The verdict was the largest of its kind in New York history (watch the video here). Two of […]

Fanelli, Kraft of Weitz & Luxenberg Recognized as New York 'Rising Stars' by Super Lawyers magazine

Hard-hitting attorneys played pivotal roles in winning multi-million dollar verdict in high profile case last year NEW YORK, Oct. 17, 2012 /PRNewswire/ — A pair of high-flying attorneys with the Manhattan law firm Weitz & Luxenberg, P.C., are among the New York legal professionals to have earned a coveted spot on Super Lawyers magazine's 2012 […]

Medical Malpractice Lawsuits Expected to Rise in Wake of U.S. Supreme Court Ruling on ObamaCare, Says Weitz & Luxenberg Attorney

As ObamaCare takes full effect, 20 million or more previously uninsured individuals will begin accessing healthcare services, but that volume may make it difficult for providers to keep pace. Some will try to stay on top of workflow by rushing. But haste will make for medical mistakes and errors — more of them than ever, […]

Victims of Abnormal Bone Fractures Await Action as FDA Lingers on Edge of Tightening Fosamax Regulations

The FDA's failure to implement heightened standards for prescription use of Fosamax has blossomed into a growing concern for doctors, who say thousands of osteoporosis patients continue to be exposed to risks NEW YORK, Feb. 23, 2012 — Doctors and other healthcare professionals have grown increasingly concerned about the regulation paradigm the Food & Drug […]

Consumer Advocates Call for Reopening of Yaz Blood Clot Risk Debate

NEW YORK, Feb. 22, 2012 — A watchdog group wants the U.S. Food and Drug Administration to reopen its debate about Yaz blood clot risks and the coagulum dangers of similar birth-control pills, including Yasmin. Many believe an extended discussion about these drospirenone-based contraceptives would be in the best interests of the millions of American […]

Weitz & Luxenberg Asbestos Cancer Lawyer – Himself Exposed to the Toxic Mineral – Hopes to Inspire Mesothelioma Victims at Feb. 12 Research Fund-raising Event in Florida

NEW YORK, Feb. 9, 2012 — A hip condition will prevent him from running in a Feb. 12 Florida race to raise funds for asbestos cancer research, but that won't stop mesothelioma attorney Kevin Mulderig of the New York-based law firm Weitz & Luxenberg, P.C., from walking to show solidarity with victims battling the rare […]

Promise Kept: N.J. Asbestos Widow's Legal Victory Fulfills Vow She Made to Dying Husband

NEW YORK, Nov. 21, 2011 — The last thing Robin Veraldo wanted was to sue. But suing was among the final wishes of her dying, cancer-stricken husband. So, the Montvale, N.J., woman went out to seek justice — and found it for the two of them. Now, Veraldo rests easier, both for having kept the […]

New York City Mass Tort and Personal Injury Litigation Law Firm Weitz & Luxenberg Commemorates Veterans Day

Arthur Luxenberg, founder of Weitz & Luxenberg, honors nation's former servicemen for national holiday NEW YORK, Nov. 11, 2011 — Weitz & Luxenberg P.C., the largest mass tort and personal injury litigation law firm in New York, today announced it will continue providing legal services and personal support to veterans, members of the armed forces […]

Study Published in JAMA Reveals Severe Infections from ReNuMoistureLoc Result in Need for Corneal Transplants inOne-Third of Infected Users, Says Weitz & Luxenburg

NEW YORK, Aug. 24, 2006 — A US research report revealed that one-third of patients with a serious eye infection associated with the ReNu with MoistureLoc product had such severe infections that they had or will need a corneal transplant. Nationally recognized mass torts and personal injury law firm Weitz & Luxenberg has spearheaded litigation […]

Weitz & Luxenberg Files Lawsuit Against Bausch & Lomb forCorneal Transplant Required After Use of ReNu withMoistureLoc

NEW YORK, May 8, 2006 — Manhattan Law Firm Weitz & Luxenberg, P.C. announces today that it has filed a lawsuit against Bausch & Lomb, the makers of the contact lens solution ReNu with MoistureLoc. Weitz & Luxenberg is investigating numerous cases and preparing to file more cases in the following days. On April 13, […]

Law Firms File Class Action Lawsuit After Guidant RecallsDefibrillators

NEW YORK, June 21, 2005 — Manhattan law firms Weitz & Luxenberg, PC and Seeger Weiss, LLP have jointly filed a class action lawsuit on behalf of patients implanted with malfunctioning defibrillators manufactured by Guidant Corporation. Guidant, which has been in acquisition talks with pharmaceutical giant Johnson & Johnson, has recalled the VENTAK PRIZM 2 […]

Law Firm Prepares for Defibrillator Cases After Guidant andMedtronic Announce Known Design Flaws

NEW YORK, May 26, 2005 – Manhattan personal injury firm Weitz & Luxenberg is seeking to help patients injured by malfunctioning defibrillators manufactured by Guidant Corporation and Medtronic Inc. It is alleged that despite knowing that the device contained a flaw that could cause a short-circuit, Guidant did not tell doctors or the 24,000 people […]

Weitz & Luxenberg Responds to Bextra Recall

NEW YORK, Apr. 7, 2005 — Since October 2004, Manhattan personal injury firm Weitz & Luxenberg has accepted new clients who have been seriously injured by the pain reducing medication Bextra. Bextra was prescribed to millions of Americans to treat the pain associated with arthritis, menstrual discomfort, and other ailments. Now, in light of the […]

Love's Labor Lost: As Baby Boomers and Their Parents Age,Law Firms Prepare for Increase in Nursing Home NegligenceCases

NEW YORK, Feb. 14, 2005 — Manhattan law firm Weitz & Luxenberg is preparing for an increase in negligence lawsuits filed by the Baby Boom generation on behalf of their aging parents. Within ten to fifteen years, the firm anticipates some older Baby Boomers will themselves be in nursing homes, and will be the plaintiffs […]

Law Firms Prepare For Celebrex Cases After Pfizer Says 1999Trial Revealed Cardiovascular Risks, Says Weitz & Luxenberg,PC

NEW YORK, Feb. 9, 2005 — Manhattan personal injury firm Weitz & Luxenberg has launched an aggressive marketing campaign seeking patients injured by the arthritis and pain medication Celebrex after the drug's manufacturer acknowledged that a 1999 clinical trial showed clear cardiovascular risks in elderly patients taking the drug. As late as October of 2004, […]